XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 29, 2021
Sep. 23, 2020
Cash flows from operating activities:    
Net income (loss) $ 34,618 $ (7,475)
Adjustments to reconcile net income (loss) to cash flows provided by (used in) operating activities:    
Depreciation and amortization 11,380 12,252
Operating (gains), losses and other charges, net 204 2,319
(Gains) losses and amortization on interest rate swap derivatives, net (14,771) 4,185
Amortization of deferred financing costs 946 591
Gains on investments (11) (117)
(Gains) losses on early termination of debt and leases (52) 43
Deferred income tax expense (benefit) 3,713 (2,505)
Share-based compensation expense 10,212 1,972
Changes in assets and liabilities:    
Receivables 4,182 7,465
Inventories (49) 265
Prepaids and other current assets 4,296 (3,865)
Other noncurrent assets (1,021) 474
Operating lease assets and liabilities (1,150) 1,231
Accounts payable 6,360 (8,540)
Accrued payroll 1,462 (8,739)
Accrued taxes 1,253 971
Other accrued liabilities 5,890 (6,512)
Other noncurrent liabilities (4,233) (5,625)
Net cash flows provided by (used in) operating activities 63,229 (11,610)
Cash flows from investing activities:    
Capital expenditures (5,321) (5,476)
Proceeds from sales of real estate and other assets 1,785 4,536
Investment purchases 0 (1,400)
Proceeds from sale of investments 200 2,900
Collections on notes receivable 539 1,385
Issuance of notes receivable (115) (670)
Net cash flows provided by (used in) investing activities (2,912) 1,275
Cash flows from financing activities:    
Revolver borrowings 181,000 140,500
Revolver payments (221,000) (150,500)
Long-term debt payments (1,583) (1,115)
Proceeds from exercise of stock options 116 212
Tax withholding on share-based payments (1,377) (3,049)
Deferred financing costs (1,809) (982)
Purchase of treasury stock (6,228) (36,008)
Proceeds from issuance of common stock 0 69,571
Net bank overdrafts (3,125) (449)
Net cash flows provided by (used in) financing activities (54,006) 18,180
Increase in cash and cash equivalents 6,311 7,845
Cash and cash equivalents at beginning of period 3,892 3,372
Cash and cash equivalents at end of period $ 10,203 $ 11,217